Literature DB >> 13824276

Cyclophosphamide. A preliminary study of a new alkylating agent.

L V FOYE, C G CHAPMAN, F M WILLETT, W S ADAMS.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS/pharmacology

Mesh：

Substances：

Year:  1960        PMID： 13824276

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  3 in total

1.  Cyclophosphamide in the treatment of myelomatosis.

Authors:  O S Choi; A English; J H Hilton; G E Catton; M D Brown
Journal:  Can Med Assoc J       Date:  1967-11-04       Impact factor: 8.262

Review 2.  Small-molecule inhibitors of DNA damage-repair pathways: an approach to overcome tumor resistance to alkylating anticancer drugs.

Authors:  Ajay Srinivasan; Barry Gold
Journal:  Future Med Chem       Date:  2012-06       Impact factor: 3.808

Review 3.  Evolution of Medical Approaches and Prominent Therapies in Breast Cancer.

Authors:  Suzann Duan; Iain L O Buxton
Journal:  Cancers (Basel)       Date:  2022-05-16       Impact factor: 6.575
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.